We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGT icon
2126
Allegiant Air
ALGT
$2.24B
-13,076
Closed -$2.56M
ALRM icon
2127
Alarm.com
ALRM
$2.82B
-8,830
Closed -$690K
ALT icon
2128
Altimmune
ALT
$605M
-74,358
Closed -$841K
ALX
2129
Alexander's
ALX
$1.35B
-2,531
Closed -$660K
AMD icon
2130
PUT
Advanced Micro Devices
AMD
$773B
-15,800
Closed -$1.63M
AMED
2131
DELISTED
Amedisys
AMED
-2,841
Closed -$424K
AMGN icon
2132
Amgen
AMGN
$238B
-18,338
Closed -$3.9M
AMKR icon
2133
Amkor Technology
AMKR
$12.5B
-44,027
Closed -$1.1M
AMLP icon
2134
Alerian MLP ETF
AMLP
$13.2B
-105,116
Closed -$3.5M
AMRN
2135
Amarin Corp
AMRN
$298M
-5,360
Closed -$547K
ANAB icon
2136
AnaptysBio
ANAB
$1.71B
-7,599
Closed -$206K
ANGO icon
2137
AngioDynamics
ANGO
$651M
-16,626
Closed -$431K
ANIP icon
2138
ANI Pharmaceuticals
ANIP
$1.73B
-6,345
Closed -$208K
ANSS
2139
DELISTED
Ansys
ANSS
-9,822
Closed -$3.34M
AOS icon
2140
A.O. Smith
AOS
$8.57B
-68,012
Closed -$4.15M
APPN icon
2141
Appian
APPN
$2.74B
-12,912
Closed -$1.19M
APTV icon
2142
Aptiv
APTV
$10B
-43,281
Closed -$6.45M
ARCC icon
2143
Ares Capital
ARCC
$14.3B
-13,353
Closed -$271K
ARCT icon
2144
Arcturus Therapeutics
ARCT
$382M
-21,937
Closed -$1.05M
ARE icon
2145
Alexandria Real Estate Equities
ARE
$9.21B
-5,872
Closed -$1.12M
ASHR icon
2146
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
-39,396
Closed -$1.5M
ATER icon
2147
Aterian
ATER
$7.82M
-1,125
Closed -$146K
LONA
2148
LeonaBio Inc
LONA
$72.4M
-1,442
Closed -$135K
ATNM icon
2149
Actinium Pharmaceuticals
ATNM
$34.5M
-17,800
Closed -$158K
ATOM icon
2150
Atomera
ATOM
$187M
-10,659
Closed -$246K

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.